NASDAQ
Callan JMB Inc. (CJMB)
♥ 361 Thanks from members
Callan JMB Inc. (CJMB) exhibits a mixed to fragile market reputation, weighed down by a $7.97M annual net loss, a Nasdaq bid-price deficiency notice, and severe past shareholder dilution, balanced against an expanded $75M equity purchase facility and niche life sciences cold chain logistics demand.